Voyager Therapeutics
VYGR
VYGR
111 hedge funds and large institutions have $526M invested in Voyager Therapeutics in 2019 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 43 increasing their positions, 33 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.34% less ownership
Funds ownership: 85.56% → 84.22% (-1.3%)
4% less funds holding
Funds holding: 116 → 111 (-5)
23% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 22
Holders
111
Holding in Top 10
2
Calls
$1.54M
Puts
$309K
Top Buyers
| 1 | +$37.3M | |
| 2 | +$7.27M | |
| 3 | +$5.94M | |
| 4 |
EAM
Erste Asset Management
Vienna,
Austria
|
+$4.59M |
| 5 |
D.E. Shaw & Co
New York
|
+$3.85M |
Top Sellers
| 1 | -$24.9M | |
| 2 | -$13.3M | |
| 3 | -$5.06M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$4.1M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$3.43M |